Cell type-specific function of LMNA during myocardial stress in the development of cardiomyopathy
心肌病发展过程中心肌应激过程中 LMNA 的细胞类型特异性功能
基本信息
- 批准号:10565904
- 负责人:
- 金额:$ 39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAffectAutophagocytosisCardiacCardiac MyocytesCardiomyopathiesCell CommunicationCell ProliferationCell physiologyComplexCongestive Heart FailureDataDefectDevelopmentDilated CardiomyopathyDiseaseDisease ProgressionElastomersExtracellular MatrixFibroblastsFibrosisFoundationsGenesHeartHeart failureHumanImpairmentIn VitroKnowledgeLamin Type ALeadLifeLinkMED25 geneMechanicsMediatingMediatorMissionModelingMolecularMusMuscle CellsMuscular AtrophyMutationMyocardialMyocardial InfarctionMyocardial dysfunctionMyocardiumNatureNeonatalOrganPathogenesisPathogenicityPathologicPathologyPhenotypePlayProductionPublic HealthRegulationResearchRestRoleSeveritiesSeverity of illnessStressSymptomsTestingTimeTissuesTransforming Growth Factor betaUndifferentiatedUnited States National Institutes of HealthVariantbiological adaptation to stresscell injurycell typeclinically relevantcoronary fibrosiseffective therapyelastomericendoplasmic reticulum stressfeature detectionheart functionhuman diseaseimprovedin vitro Modelin vivoin vivo Modelinduced pluripotent stem cellinsightlamin Cmembermigrationmodel designmutantnovelnovel strategiesnovel therapeuticspreservationpreventresponsetargeted treatmenttherapy development
项目摘要
Project Summary
Mutations in the LMNA gene encoding lamin A/C cause a diverse group of human diseases termed
laminopathies. The most prevalent laminopathy is dilated cardiomyopathy (herein referred to as LMNA
cardiomyopathy). Despite recent progress in understanding the diverse cellular function of lamin A/C, what
pathogenic mechanisms are triggered by LMNA mutations in specific cell types of the myocardium and how they
are integrated at the tissue level to produce a cardiac phenotype is largely unknown. The prevailing view is that
LMNA mutations cause a myriad of cellular defects that all contribute to the disease but this broad assertion has
never been rigorously tested. Our preliminary data suggest that lamin A/C play a crucial role in cardiac fibroblasts
(CF) function in fibrosis and the onset and/or the pathogenicity of LMNA cardiomyopathy is more severe if the
lamin A/C function is selectively impaired in cardiomyocytes (CM). In vivo Lmna deletion specifically in adult CMs
caused rapid onset of fibrosis and severe cardiac dysfunction. In contrast, Lmna deletion in CFs displayed no
immediate cardiac pathology. Surprisingly, relative to CM-deletion alone, concomitant deletion of Lmna in CMs
and CFs resulted in lesser fibrosis and pathological remodeling. These results suggest that lamin A/C in CFs
play a crucial role in the development of fibrosis/cardiac remodeling and that these pathological features underlie
the disease progression and severity in response to CM stress. At the molecular level, we implicate increased
matrix stiffness from fibrosis contribute to CM expression of ER stress markers and MED25, which is a member
of the Mediator complex identified as a regulator of ER stress responses. Taken together, our results suggest
lamin A/C-depleted CFs mediate a brake on cardiomyopathy development and interactions between CFs and
CMs are important determinants of the rate of progression and the severity of LMNA cardiomyopathy.
Based on our preliminary data, we hypothesize that lamin A/C contribute to the pathogenesis of LMNA
cardiomyopathy in an opposing manner depending on the cell type; lamin A/C promote CF-mediated fibrosis in
response to myocardial stress while in parallel protect CMs from ER stress and cell damage. To test our
hypothesis, Aim1 will determine whether lamin A/C regulation of CF function underlies the rate and the severity
of disease progression. We will elucidate the putative mechanisms by which Lmna deletion impairs CF function
in the stressed myocardium. In Aim2, we will determine how the mechanical component of fibrosis contributes
to CM damage caused by LMNA mutations. Under varying matrix stiffness, we will delineate the mechanism
underlying CM damage caused by LMNA mutations and contextualize the involvement of ER stress. These aims
will not only lead to a better understanding of lamin A/C function in CFs, CMs, and their crosstalk in disease
pathogenesis but may also enable the development of new therapies for LMNA cardiomyopathy and perhaps
other forms of cardiomyopathies in which fibrosis is integral to their pathogenesis.
项目摘要
编码核纤层蛋白A/C的LMNA基因的突变导致一组不同的人类疾病,称为
核纤层蛋白病最普遍的核纤层蛋白病是扩张型心肌病(本文称为LMNA
心肌病)。尽管最近在理解核纤层蛋白A/C的多种细胞功能方面取得了进展,
致病机制是由心肌特定细胞类型中的LMNA突变触发的,
在组织水平上整合以产生心脏表型在很大程度上是未知的。普遍的看法是,
LMNA突变导致无数的细胞缺陷,所有这些都有助于疾病,但这一广泛的断言,
从未经过严格测试。我们的初步数据表明,核纤层蛋白A/C在心脏成纤维细胞中起关键作用
(CF)在纤维化中的作用,如果LMNA心肌病的发病和/或致病性更严重,
心肌细胞(CM)中层蛋白A/C功能选择性受损。在成年CM中特异性的体内Lmna缺失
导致纤维化和严重的心功能不全相比之下,CF中的Lmna缺失显示没有
即刻心脏病理学检查。令人惊讶的是,相对于单独的CM-缺失,CM中Lmna的伴随缺失
而CF导致较少的纤维化和病理性重塑。这些结果表明,CF中的核纤层蛋白A/C
在纤维化/心脏重塑的发展中起着至关重要的作用,这些病理特征是
对CM应激的反应的疾病进展和严重程度。在分子水平上,我们暗示
纤维化引起的基质硬度有助于CM表达ER应激标志物和MED 25,MED 25是CM的一个成员。
作为ER应激反应的调节剂。综合来看,我们的结果表明
核纤层蛋白A/C缺失的CF介导心肌病发展的制动以及CF与
CM是LMNA心肌病进展速度和严重程度的重要决定因素。
基于我们的初步数据,我们假设核纤层蛋白A/C参与了LMNA的发病机制
核纤层蛋白A/C促进CF介导的纤维化,
同时保护CM免受ER应激和细胞损伤。来测试我们
假设,Aim 1将确定核纤层蛋白A/C调节CF功能是否是CF功能的速率和严重程度的基础。
疾病的发展。我们将阐明Lmna缺失损害CF功能的假定机制
在应激心肌中。在Aim 2中,我们将确定纤维化的机械成分如何贡献
由LMNA突变引起的CM损伤。在不同的基质刚度下,我们将描绘出
潜在的CM损害引起的LMNA突变和情境参与ER应激。这些目标
不仅可以更好地理解CF、CM中核纤层蛋白A/C的功能,
发病机制,但也可能使LMNA心肌病的新疗法的发展,
其他形式的心肌病,其中纤维化是其发病机制的组成部分。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Med25 Limits Master Regulators That Govern Adipogenesis.
- DOI:10.3390/ijms24076155
- 发表时间:2023-03-24
- 期刊:
- 影响因子:5.6
- 作者:Saunders, Jasmine;Sikder, Kunal;Phillips, Elizabeth;Ishwar, Anurag;Mothy, David;Margulies, Kenneth B. B.;Choi, Jason C. C.
- 通讯作者:Choi, Jason C. C.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason Cheol Choi其他文献
Jason Cheol Choi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason Cheol Choi', 18)}}的其他基金
Cell type-specific function of LMNA during myocardial stress in the development of cardiomyopathy
心肌病发展过程中心肌应激过程中 LMNA 的细胞类型特异性功能
- 批准号:
10357670 - 财政年份:2020
- 资助金额:
$ 39万 - 项目类别:
Dusp4 in the pathogenesis of LMNA cardiomyopathy
Dusp4在LMNA心肌病发病机制中的作用
- 批准号:
9207012 - 财政年份:2016
- 资助金额:
$ 39万 - 项目类别:
Dusp4 in the pathogenesis of LMNA cardiomyopathy
Dusp4在LMNA心肌病发病机制中的作用
- 批准号:
8487168 - 财政年份:2013
- 资助金额:
$ 39万 - 项目类别:
Molecular and Cellular Pathogenesis of Emery-Dreifuss Muscular Dystrophy
Emery-Dreifuss 肌营养不良症的分子和细胞发病机制
- 批准号:
8215808 - 财政年份:2010
- 资助金额:
$ 39万 - 项目类别:
Molecular and Cellular Pathogenesis of Emery-Dreifuss Muscular Dystrophy
Emery-Dreifuss 肌营养不良症的分子和细胞发病机制
- 批准号:
7808357 - 财政年份:2010
- 资助金额:
$ 39万 - 项目类别:
Molecular and Cellular Pathogenesis of Emery-Dreifuss Muscular Dystrophy
Emery-Dreifuss 肌营养不良症的分子和细胞发病机制
- 批准号:
8018139 - 财政年份:2010
- 资助金额:
$ 39万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 39万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)